jiayi-li23/proxann_data huggingface dataset:
Bill 113-HR-4384 — Health / R&D
Subject: Health

America Helping Encourage Advancements in Lifesaving Science or the America HEALS Act - Establishes a Biomedical Research Fund to be administered by the Secretary of the Treasury to provide for an expanded and sustained national investment in biomedical research.

Requires amounts to be transferred from the Fund for each fiscal year to accounts related to the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), the Department of Defense (DOD) health program, and the medical and prosthetics research program of the Department of Veterans Affairs (VA) to ensure that funding for such programs and agencies does not fall below 105% of the level of funding provided for the preceding fiscal year and an additional amount to account for any increases in the Gross Domestic Product for the year involved.

Requires that amounts appropriated for each of such programs and agencies for a fiscal year be not be less than the amounts appropriated for FY2014. Authorizes and appropriates to the Fund such sums as necessary in each fiscal year to enable such transfers.

Amends the Balanced Budget and Emergency Deficit Control Act to exempt the Fund from any sequestration order issued under such Act.
Bill 113-HR-4418 — Health / R&D
Subject: Health

Expanding the Availability of Medicare Data Act - Expands the kinds of uses of Medicare data available to qualified entities for quality and patient care improvement activities.

(A "qualified entity" is a public or private entity that: [1] is qualified to use claims data to evaluate the performance of service providers and suppliers on measures of quality, efficiency, effectiveness, and resource use; and [2] agrees to meet specified requirements, such as ensuring data security.) Authorizes a qualified entity to use claims data combined with non-claims data the entity has received, as well as information derived from evaluation of service provider and supplier performance, to conduct additional non-public analyses and provide or sell them to authorized users for non-public use (including to assist service providers and suppliers to develop and participate in quality and patient care improvement activities, including new models of care).

Defines "authorized users" as service providers, suppliers, employers, health insurance issuers, medical societies or hospital associations, or any other entities approved by the Secretary of Health and Human Services (HHS).

Prohibits a qualified entity from charging a fee to provide Medicare claims data.

Requires a qualified entity and an authorized user to enter into a data use agreement, and prohibits the use of data or analyses for marketing purposes or, except in certain circumstances, its redisclosure.

Directs the Secretary to provide Medicare data to qualified clinical data registries for purposes of linking it with clinical outcomes data and performing risk-adjusted, scientifically valid analyses and research to support quality improvement or patient safety. Requires charging a fee to a registry for such data.

Amends title XVIII (Medicare) of the Social Security Act (SSA) to include among standardized extracts of Medicare claims data that may be made available to qualified entities, if the Secretary determines appropriate, also claims data under SSA titles XIX (Medicaid) and XXI (State Children's Health Insurance) (CHIP).

Requires any fees charged for making standardized extracts available to qualified entities to be deposited into the Centers for Medicare & Medicaid Services Program Management Account (currently, into the Federal Supplementary Medical Insurance Trust Fund).
Bill 113-HR-4494 — Health / R&D
Subject: Health

Regenerative Medicine Promotion Act of 2014 - Requires the Comptroller General to submit to Congress a report identifying all ongoing federal programs and activities regarding regenerative medicine.

Directs the Secretary of Health and Human Services (HHS) to establish a Regenerative Medicine Coordinating Council in the Office of the Secretary with duties to include: (1) preparing a national strategy to support research into regenerative medicine and the development of drugs, biological products, medical devices, and biomaterials for use in regenerative medicine; (2) identifying sources of funding for research into regenerative medicine and areas where such funding is inadequate; and (3) making recommendations regarding federal policies to support development and marketing of regenerative medicine products.

Authorizes the Secretary, acting through the Director of the National Institutes of Health (NIH), to make grants for: (1) basic or preclinical research into regenerative medicine; (2) research and development of drugs, biological products, medical devices, and biomaterials for use in regenerative medicine; and (3) the making of an investigational new drug application or an investigational device exemption application within four years of receiving such grant.

Amends the Public Health Service Act to authorize the Director of NIH to award grants, contracts, or cooperative agreements to accelerate the development of high need cures through the development of medical products and behavioral therapies for use in regenerative medicine.

Authorizes the Secretary, acting through the Commissioner of Food and Drugs, to: (1) conduct, support, or collaborate in regulatory research to assist the Food and Drug Administration (FDA) in performing its functions with respect to regenerative medicine; or (2) make grants to fund regulatory research for such purpose.
Bill 113-HR-4701 — Health / R&D
Subject: Health

Tick-Borne Disease Research Accountability and Transparency Act of 2014 - Amends the Public Health Service Act to require the Secretary of Health and Human Services (HHS) to conduct or support epidemiological, basic, translational, and clinical research regarding Lyme disease and other tick-borne diseases.

Directs the Secretary to establish the Interagency Lyme and Tick-Borne Disease Working Group to review all HHS efforts concerning tick-borne diseases to ensure interagency coordination and examine research priorities. Requires the Working Group to: (1) provide a summary of tick-borne disease research, advances, and scientific viewpoints every two years; (2) make recommendations to HHS regarding tick-borne disease activities; and (3) hold annual public meetings.

Requires HHS to submit a strategic plan for tick-borne disease research within three years of enactment and every five years thereafter that includes: (1) budgetary requirements; (2) benchmarks for improving tick-borne disease diagnosis, treatment, outcomes, and prevention; and (3) a plan to disseminate Working Group summaries and other relevant information on tick-borne disease to health professionals and the public.
Bill 113-HR-4798 — Health / R&D
Subject: Health

United States-Israel Alzheimer's Disease Cooperation Act - Directs the Secretary of Health and Human Services (HHS) to establish a program of grants to support research on the development and commercialization of tools, treatments, and cures for Alzheimer's disease and other dementias.

Requires eligible projects to be joint ventures between U.S. and Israeli non-governmental entities or the U.S. and Israeli governments.

Establishes an advisory board to monitor the method by which grants are awarded and to provide performance reviews of actions taken to carry out this Act.
Bill 113-HR-4847 — Health / R&D
Subject: Health

End Neglected Tropical Diseases Act - Defines "neglected tropical diseases" (NTDs), for purposes of this Act, as infections caused by pathogens, including viruses, bacteria, protozoa, and helminths that disproportionately impact individuals living in extreme poverty, especially in developing countries.

Expresses the sense of Congress that the Neglected Tropical Diseases Program of the U.S. Agency for International Development (USAID) should be modified with respect to rapid impact package treatments, school-based NTD programs, and new approaches to reach the goals of eliminating NTDs set forth by the World Health Organization. Sets forth measures to expand the USAID program, including by establishment of a research and development program.

Adds to the duties of the of the Coordinator of United States Government Activities to Combat HIV/AIDS Globally the coordination with HIV/AIDS activities of those relating to combatting NTDs, particularly in countries and regions that are highly endemic for female genital schistosomiasis.

Urges the Secretary of State to: (1) engage the Global Fund to Fight AIDS, Tuberculosis and Malaria in discussions of whether to expand the authority of the Fund for the control and elimination of NTDs; and (2) engage G-20 countries to significantly increase their role in the that effort, particularly Argentina, Brazil, China, India, Indonesia, Mexico, the Republic of Korea, Saudi Arabia, and South Africa.

Requires the President to direct the U.S. representatives to the United Nations and the International Bank for Reconstruction and Development to urge actions on NTDs, including deworming programs.

Requires the Secretary of Health and Human Services (HHS) to:

 continue to promote the need for NTD programs and activities through interagency groups and international forums, report to Congress on NTDs in the United States, enter into cooperative agreements to support one or more centers of excellence for NTD research. Requires the Director of the National Institutes of Health (NIH) to establish a panel to evaluate issues relating to worm infections, including potential solutions such as deworming medicines.
Bill 113-HR-4852 — Health / R&D
Subject: Armed forces and national security

Wounded Warrior Research Enhancement Act - Directs the Secretary of Defense (DOD) to award grants to carry out research for the advancement of orthotic and prosthetic clinical care for members of the Armed Forces, veterans, and civilians who have undergone amputation, traumatic brain injury, and other serious physical injury as a result of combat or military experience. Includes under such research the prevention of amputations, orthotic and prosthetic intervention, and orthotics and prosthetic materials and technology research.
Bill 113-HR-4887 — Health / R&D
Subject: Armed forces and national security

Expanding Care for Veterans Act - Directs the Secretary of Veterans Affairs (VA) to develop a plan to expand the scope of the VA's research and education on, and delivery and integration of, complementary and alternative medicine services.

Requires the Secretary to carry out, through the VA's Office of Patient Centered Care and Cultural Transformation, a three-year program to: (1) assess the feasibility and advisability of integrating the delivery of complementary and alternative medicine services selected by the Secretary with other VA health care services for veterans, and (2) identify and resolve barriers to providing such services and integrating them with other VA health services.

Requires such program to be conducted, at not fewer than 15 VA medical centers, by integrating the provision of complementary and alternative medicine services with other VA health care services provided to veterans who have a mental health condition, experience chronic pain, or have a chronic condition. Requires veterans' participation to be voluntary.

Directs the Secretary to contract with a qualified independent entity for comprehensive studies of the barriers encountered by veterans in receiving, and by administrators and clinicians in providing, complementary and alternative medicine services through the VA. Provides for the conduct of such studies through surveys of veterans and VA administrators and clinicians.

Requires the Secretary to carry out a three-year program awarding grants to public or private nonprofit entities to assess the feasibility and advisability of using wellness programs to complement the provision of mental health care to veterans and family members who are eligible for readjustment counseling from the VA.
Bill 113-HR-4944 — Health / R&D
Subject: Health

Neglected Infections of Impoverished Americans Act of 2014 - Requires the Secretary of Health and Human Services (HHS) to report to Congress on the epidemiology of, impact of, and appropriate funding required to address neglected diseases of poverty, including neglected parasitic diseases such as Chagas disease, cysticercosis, toxocariasis, toxoplasmosis, trichomoniasis, the soil-transmitted helminths, and other related diseases. Requires the report to provide the information necessary to guide future health policy to: (1) accurately evaluate the current state of knowledge concerning such diseases and define gaps in such knowledge, and (2) address the threat of such diseases.
Bill 113-HR-5183 — Health / R&D
Subject: Health

Value Based Insurance Design for Better Care Act of 2014 or the VBID for Better Care Act of 2014 - Directs the Secretary of Health and Human Services (HHS) to establish a three-year demonstration program to test the use of value-based insurance design methodologies under the eligible Medicare plans offered by Medicare Advantage organizations under part C (Medicare+Choice) of title XVIII (Medicare) of the Social Security Act.

Defines "value-based insurance design methodology" as one for identifying specific prescription medications, and clinical services reimbursable under Medicare, for which copayments, coinsurance, or both should be reduced or eliminated because of the high-value and effectiveness of these medications and services for specific chronic clinical conditions (as approved by the Secretary).

Directs the Secretary to expand the demonstration program to implement, on a permanent basis, those components beneficial to Medicare beneficiaries and the Medicare program, unless a required evaluation of the program states that it: (1) increases expenditures under Medicare with respect to participating beneficiaries, or (2) decreases the quality of health care services furnished to such beneficiaries.
Bill 113-HR-5214 — Health / R&D
Subject: Health

(Sec. 1) Requires the Department of Health and Human Services (HHS) to consult with clinical experts and make recommendations for the use of clinical data registries to improve patient care.

Directs HHS to include in the recommendations: (1) standards to allow exchange of information between electronic health records and registries, (2) how registries can be used to evaluate models and methods of care, (3) how registries can be used to monitor the safety and efficacy of products approved by the Food and Drug Administration (FDA), (4) how registry data can inform health care professionals on the prevention of disease and how educational resources derived from registry data can be disseminated, and (5) how registries can promote preventive health care.
Bill 113-HR-5507 — Health / R&D
Subject: Health

Reducing Disparities Using Care Models and Education Act of 2014 - Requires the Secretary of Health and Human Services (HHS) to contract with the Institute of Medicine to study: (1) health disparities; (2) existing programs and policies intended to reduce disparities; and (3) priorities for, and expansion of, programs targeting disparities.

Requires the Secretary to develop guidelines for entities to develop and implement programs to reduce health disparities. Directs the Secretary to incorporate these guidelines into HHS activities.

Authorizes the Secretary to award grants for programs to reduce health disparities.

Requires the Innovation Center of the Centers for Medicare and Medicaid Services (CMS) to test a payment and service delivery model that includes incentives for reducing health disparities.
Bill 113-HR-5544 — Health / R&D
Subject: Health

Low-Dose Radiation Research Act of 2014 - Requires the Director of the Department of Energy (DOE) Office of Science to carry out a research program on low dose radiation to enhance the scientific understanding of and reduce uncertainties associated with the effects of exposure to low dose radiation.

Requires the Director to enter into an agreement with the National Academies to conduct a study assessing the current status and development of a long-term strategy for low dose radiation research.

Requires such study to:

 identify current scientific challenges for understanding the long-term effects of ionizing radiation, assess the status of current low dose radiation research, formulate overall scientific goals for the future of low-dose radiation research, recommend a long-term strategic and prioritized research agenda to address scientific research goals for overcoming the identified scientific challenges in coordination with other research efforts, define the essential components of a research program that would address this research agenda within the universities and the National Laboratories, and assess the effectiveness of such a program. Directs the Secretary of Energy to deliver to Congress a five-year research plan that responds to the study's findings and recommendations and identifies and prioritizes research needs.

Makes DOE's limitation on human research inapplicable to research under this Act.
Bill 113-HR-5580 — Health / R&D
Subject: Health

Accelerating Biomedical Research Act - Amends the Balanced Budget and Emergency Deficit Control Act of 1985 to require certain adjustments to discretionary spending limits in FY2015-FY2021 to accommodate increases in appropriations to the National Institutes of Health (NIH) at the Department of Health and Human Services (HHS).
Bill 113-HR-5724 — Health / R&D
Subject: Health

Permanent Investment in Health Research Act of 2014 - Amends the Public Health Service Act to replace the current authorization of appropriations for the National Institutes of Health (NIH) with specified actual appropriations for FY2015-FY2024.

Appropriates $32 billion for FY2015, and for each of FY2016-FY2024 the amount for the preceding fiscal year adjusted by the percentage increase in nominal gross domestic product during the preceding calendar year.

Amends the Balanced Budget and Emergency Deficit Control Act of 1985 (Gramm-Rudman-Hollings Act) to add NIH to the list of programs and activities that are exempt from a sequestration. (A sequestration is a process of automatic, usually across-the-board spending reductions under which budgetary resources are permanently canceled to enforce specific budget policy goals.)
Bill 113-HR-5729 — Health / R&D
Subject: Health

Adding Ebola to the FDA Priority Review Voucher Program Act - Amends the Federal Food, Drug, and Cosmetic Act to add filoviruses, a family of viruses that includes the Ebola virus, to the list of tropical diseases under the priority review voucher program, which awards vouchers to sponsors of human drug applications that are approved to prevent or treat tropical diseases. (A voucher entitles the holder to have a future human drug application acted upon by the Food and Drug Administration (FDA) within six months.)

Changes the process by which infectious diseases that do not significantly impact developed nations and disproportionately affect poor and marginalized populations can be designated as tropical diseases from rulemaking to order of the Secretary of Health and Human Services (HHS).

Allows priority review vouchers to be transferred between sponsors of human drug applications any number of times.

Reduces from 365 days to 90 days the advance notice required before submitting a human drug application subject to a priority review voucher.
Bill 113-HR-5790 — Health / R&D
Subject: Health

Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014 - Amends the Public Health Service Act to require the Director of the National Institutes of Health (NIH) to design prize competitions open to competitors worldwide to realize innovations that improve health outcomes thereby reducing federal expenditures on health programs.

Requires the NIH to identify as the subject of the competitions diseases or health conditions for which the federal government spends at least $5 billion per year on prevention and treatment, and the research investment is disproportionately small in comparison to other diseases with similar or greater federal expenditures on treatment and prevention.

Directs the NIH to award contracts to perform a simulation of the designed prize competitions to assess the effectiveness of the design.

Requires the NIH to contract with private entities to implement the competitions.

Allows the Secretary of Health and Human Services (HHS) and the Food and Drug Administration (FDA) to provide competitors with guidance and access to testing facilities.

Prohibits the federal government from gaining an interest in intellectual property development by a participant without the participant's written consent.

Amends the Internal Revenue Code to exclude prizes from gross income.
Bill 113-HR-5819 — Health / R&D
Subject: Science, technology, communications

Funding Scientists at the Peak Age of Discovery Act of 2014 - Amends the Public Health Service Act to require the Director of the National Institutes of Health (NIH) to ensure that the median age of first-time researchers receiving R series (research) grants is under 40 years of age by January 1, 2019, under 39 years of age by January 1, 2022, and under 38 years of age by January 1, 2025. Excludes grants for small business innovation research, small business technology transfer, or clinical trial planning.
Bill 113-HR-5820 — Health / R&D
Subject: Science, technology, communications

YES to Cures Act of 2014 - Amends the Public Health Service Act to require the Secretary of Health and Human Services (HHS) to allocate for research by emerging scientists funds that otherwise would be used to evaluate the implementation and effectiveness of National Institutes of Health (NIH) programs.

Requires NIH to explain why there has been an increase in the average age of grant recipients over the past 30 years and describe the steps taken to address this trend.
Bill 113-S-50 — Health / R&D
Subject: Environmental protection

Strengthening Protections for Children and Communities From Disease Clusters Act - Requires the Administrator of the Environmental Protection Agency (EPA) to: (1) develop, publish, and update guidelines on an approach to investigate suspected or potential disease clusters, environmental pollutants or toxic substances associated with such clusters, or potential causes of such clusters; (2) establish and operate Regional Disease Cluster Information and Response Centers and Regional Disease Cluster Information and Response Teams; (3) ensure that the Office of Children's Health Protection has a prominent role in developing and updating such guidelines and in establishing and operating such Centers and Teams; (4) establish Community Disease Cluster Advisory Committees to provide oversight, guidance, and advice relating to such investigations; (5) provide support to individuals on such Teams and Committees through grants and cooperative agreements with institutions of higher education; (6) compile and update a publicly available, online database that provides information relating to disease clusters; and (7) use available authorities and programs to compile, research, and analyze information generated by actions authorized under this Act.

Authorizes any person to submit a petition to the EPA Administrator, the Administrator of the Agency for Toxic Substances and Disease Registry, and the Director of the National Institute of Environmental Health Sciences that requests that a Response Team conduct an investigation or take action to address the potential causes of disease clusters.

Authorizes the Administrator to make grants to any group of individuals that may be affected by such clusters.